Holen Sie sich die Stockscreener-App
0.0352
77.13%
-0.1187
Schlusskurs vom Vortag:
$0.1539
Offen:
$0.0327
24-Stunden-Volumen:
2.01M
Relative Volume:
0.26
Marktkapitalisierung:
$1.47M
Einnahmen:
$20.27M
Nettoeinkommen (Verlust:
$-63.80M
KGV:
-0.0232
EPS:
-1.52
Netto-Cashflow:
$-68.35M
1W Leistung:
-86.96%
1M Leistung:
-89.82%
6M Leistung:
-82.13%
1J Leistung:
-96.29%
1-Tages-Spanne:
$0.0261
$0.0407
1-Wochen-Bereich:
$0.0261
$0.29
52-Wochen-Spanne:
$0.0261
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
Firmenname
Carisma Therapeutics Inc
Sektor
Branche
Telefon
(267) 491-6422
Adresse
3675 MARKET STREET, PHILADELPHIA
Vergleichen Sie CARM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.0352 | 6.43M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.50 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
473.46 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.82 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
813.72 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.03 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-04-11 | Eingeleitet | BTIG Research | Buy |
| 2023-10-03 | Eingeleitet | CapitalOne | Overweight |
| 2023-07-06 | Eingeleitet | Evercore ISI | Outperform |
| 2023-05-31 | Hochstufung | Jefferies | Hold → Buy |
| 2023-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-14 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Carisma Therapeutics Inc Aktie (CARM) Neueste Nachrichten
Published on: 2025-10-15 11:31:31 - newser.com
Does Carisma Therapeutics Inc. (W2J) stock trade below intrinsic valueStop Loss & Verified Momentum Stock Watchlist - newser.com
Understanding Carisma Therapeutics Inc.’s price movementWeekly Trend Report & Fast Entry High Yield Tips - newser.com
Analyzing recovery setups for Carisma Therapeutics Inc. investorsDollar Strength & High Conviction Investment Ideas - newser.com
Using Bollinger Bands to evaluate Carisma Therapeutics Inc.Trade Risk Assessment & Daily Technical Forecast Reports - newser.com
Is Carisma Therapeutics Inc. a candidate for recovery playQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Key metrics from Carisma Therapeutics Inc.’s quarterly data2025 Institutional Moves & Weekly Market Pulse Updates - newser.com
Carisma Therapeutics, Inc.(NasdaqCM: CARM) dropped from S&P TMI Index - MarketScreener
Volatility clustering patterns for Carisma Therapeutics Inc.2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com
Is Carisma Therapeutics Inc. stock positioned for digital transformationPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Visual trend scoring systems applied to Carisma Therapeutics Inc.July 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-13 10:57:01 - newser.com
Heatmap analysis for Carisma Therapeutics Inc. and competitorsEarnings Recap Summary & Fast Entry High Yield Stock Tips - newser.com
Will Carisma Therapeutics Inc. stock go up soonWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
How hedge fund analytics apply to Carisma Therapeutics Inc. stockJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
What analyst consensus says on Carisma Therapeutics Inc. stockGap Down & Weekly Top Performers Watchlists - newser.com
What MACD trends signal for Carisma Therapeutics Inc. (W2J) stock2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
Dow Surges 150 Points; US Consumer Sentiment Edges Lower - Benzinga
Carisma Therapeutics stock plunges after Nasdaq delisting notice By Investing.com - Investing.com Nigeria
Carisma Therapeutics stock plunges after Nasdaq delisting notice - Investing.com
Can Carisma Therapeutics Inc. (W2J) stock sustain free cash flowJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Carisma Therapeutics Faces Nasdaq Delisting and Trading Suspension - TipRanks
Top Executive Sells Thousands of Carisma Therapeutics Shares! - TipRanks
Carisma Therapeutics CSO Sells Shares - TradingView
Is Carisma Therapeutics Inc a good long term investmentTechnology Stock Trends & Free Trend Following Techniques - earlytimes.in
Is Carisma Therapeutics Inc W2J a good long term investmentVolume Weighted Average Price & Low Entry Investment Portfolio - earlytimes.in
Chart overlay techniques for tracking Carisma Therapeutics Inc.Earnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
Can machine learning forecast Carisma Therapeutics Inc. recoveryJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Advanced analytics toolkit walkthrough for Carisma Therapeutics Inc.Weekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Is Carisma Therapeutics Inc. stock attractive for passive investorsPortfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
How analysts revise price targets for Carisma Therapeutics Inc. (W2J) stockInsider Selling & AI Enhanced Trading Alerts - newser.com
Why Carisma Therapeutics Inc. (W2J) stock is listed among top recommendationsEarnings Risk Report & Fast Gain Stock Tips - newser.com
Should you wait for a breakout in Carisma Therapeutics Inc.2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
P 500 performance this yearJuly 2025 PostEarnings & High Yield Stock Recommendations - newser.com
Finanzdaten der Carisma Therapeutics Inc-Aktie (CARM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Carisma Therapeutics Inc-Aktie (CARM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Klichinsky Michael | Chief Scientific Officer |
Oct 07 '25 |
Sale |
0.25 |
56,982 |
14,485 |
0 |
5.33%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):